Investment strategist names 10 sub-$10 billion stocks to watch in 2026

Investment strategist Shay Boloor has outlined ten sub-$10 billion market-cap companies he believes are positioned to benefit from powerful long-term trends heading into 2026.

Finbold • Dec 13, 2025

Reasons to Retain TransMedics Stock in Your Portfolio for Now

TMDX gains momentum as OCS technology, a robust pipeline and strong Q3 results fuel growth, though gross margin pressure tempers the outlook.

Zacks Investment Research • Dec 10, 2025

Looking For A Squeeze? Top 10 Most Shorted Stocks Right Now

Traders typically look for heavily shorted stocks for two main reasons: either to bet on a decline in the company's value or to profit from a short squeeze.

Benzinga • Dec 10, 2025

2 Under-the-Radar Stocks That Have Soared This Year

TransMedics Group's revolutionary organ care system is driving its strong results. Abivax is a David among Goliaths, and its growth story might just be getting started.

The Motley Fool • Dec 9, 2025

TransMedics Director Sells 4,142 Shares as Wall Street Maintains Buy Ratings: Is the Stock Still a Buy?

Director Edward Basile executed an exercise of 4,142 options with immediate sale of all resulting shares in TransMedics Group (TMDX +0.07%) on October 29, 2025, as disclosed in the SEC Form 4 filing.

The Motley Fool • Dec 8, 2025

Why TransMedics (TMDX) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Dec 5, 2025

3 Top Stocks to Buy in December

MercadoLibre has tremendous potential in the Latin American e-commerce and fintech markets. TransMedics Group is preparing to expand into Italy and has plenty of room to grow in the U.S. as well.

The Motley Fool • Dec 2, 2025

1 Growth Stock I'm Thankful for -- and the Unstoppable Stock I'm Buying Using the Lessons It Taught Me

As contradictory as it may sound, my most financially painful transaction has been one of my best investing lessons. These lessons apply to many stocks that I hold, but one in particular stands out today.

The Motley Fool • Nov 25, 2025

TransMedics (TMDX) Just Overtook the 20-Day Moving Average

From a technical perspective, TransMedics (TMDX) is looking like an interesting pick, as it just reached a key level of support. TMDX recently overtook the 20-day moving average, and this suggests a short-term bullish trend.

Zacks Investment Research • Nov 20, 2025

TransMedics (TMDX) Crossed Above the 50-Day Moving Average: What That Means for Investors

TransMedics (TMDX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, TMDX broke through the 50-day moving average, which suggests a short-term bullish trend.

Zacks Investment Research • Nov 20, 2025